Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-025196
Filing Date
2016-07-15
Accepted
2016-07-15 16:01:29
Documents
1
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4059
  Complete submission text file 0000899243-16-025196.txt   5553
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Pourhassan Nader (Reporting) CIK: 0001532878 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-49908 | Film No.: 161769710